Novogen's NV-128 Is a Unique Inhibitor of mTOR Dephosphorylation Leading to Caspase Independent Death in Chemoresistant Cancer Cells
15 avr. 2008 17h25 HE
|
Novogen, Limited
SAN DIEGO, CA--(Marketwire - April 15, 2008) - Pre-clinical studies reviewed during an oral
presentation here today at the annual meeting of the American Association
for Cancer Research demonstrate...